Skip to main navigation
Molecular Partners

> Top Menu

  • Partnering
  • Careers
  • Contact Us

> Investor Relations

  • About Us
  • DARPin Biology
  • The DARPin Platform
  • Pipeline
  • Investors
    • Overview
    • News & Events
      • News Releases
      • Events
      • Presentations
    • Scientific Documents
    • Stock Information
      • Stock Quote & Chart
      • Historic Price Lookup
      • Investment Calculator
      • Analyst Coverage
    • Corporate Governance
      • Documents & Charters
      • Management Team & Board of Directors
      • Committee Composition
      • Major Shareholders
      • Management Transactions
    • Ethics & Compliance
    • Financials & Filings
      • SEC Filings
      • Financial Reports
    • General Meeting
    • IR Resources
      • Email Alerts
      • Contact IR

> Investor Relations

  • About Us
  • DARPin Biology
  • The DARPin Platform
  • Pipeline
  • Investors
    • « Back
    • Overview
    • News & Events
      • « Back
      • News Releases
      • Events
      • Presentations
    • Scientific Documents
    • Stock Information
      • « Back
      • Stock Quote & Chart
      • Historic Price Lookup
      • Investment Calculator
      • Analyst Coverage
    • Corporate Governance
      • « Back
      • Documents & Charters
      • Management Team & Board of Directors
      • Committee Composition
      • Major Shareholders
      • Management Transactions
    • Ethics & Compliance
    • Financials & Filings
      • « Back
      • SEC Filings
      • Financial Reports
    • General Meeting
    • IR Resources
      • « Back
      • Email Alerts
      • Contact IR

Investors

Investors

SHARE PRICE

> View All Stock

  • Detailed Share Information
Latest News
Interim Management Statement Q1 2022 of Molecular Partners: Cash Runway into 2026 and Portfolio Progress Highlight Strategic Momentum
Molecular Partners to Participate in Upcoming Healthcare Investor Conferences
Molecular Partners CEO, Patrick Amstutz, Elected President of the Swiss Biotech Association

> View All News

  • All News
Upcoming Events
More events are coming soon.

> View All Events

  • All Events
Latest Presentation
May 16, 2022
MP Corporate Presentation
April 25, 2022
Kempen Conference Presentation
March 16, 2022
Publication of full year results 2021

> View All Presentations

  • All Presentations
Latest Financial Documents
May 12, 2022
Q1 2022 Financial Statement
March 15, 2022
Annual Report FY2021
October 28, 2021
Q3 2021 Financial Statement

> View All Reports

  • All Annual Report
Seth Lewis

Seth Lewis,
SVP Investor Relations,
Communications and Strategy

Contact Seth

STAY INFORMED

Subscribe to email alerts of your choosing

SUBSCRIBE

Institutional investors:

  REQUEST 1-1 / CALL

powered by schedulR

> Footer Menu

  • Cookie Notice
  • Privacy & Disclaimer
  • Contact Us

> Footer Social

© 2022 Molecular Partners.